83 drugs, none of which are sold in these hospitals (with a list attached)

Pharmaceutical Network February 22 - February 20, Heilongjiang Province Medical Security Bureau issued "on the suspension of the quality and efficacy of non-passed generic drugs to evaluate the qualifications of online drug trading."according to the relevant regulations, according to the relevant regulations, amosirin capsules (0.25g), oxalic acid essic pyrran tablets (10mg), Nitikawe dispersion tablets (0.5mg), Nitikawe capsules (0.5mg) and other four products of thethrough the quality and efficacy consistency evaluation of the production of 3(as of February 15, 2019)therefore, the suspension of the above product regulations did not pass the quality and efficacy consistency evaluation of the production enterprises of the drug in Heilongjiang drug concentrationplatform trading qualificationsA total of 83 varieties, involving 64 pharmaceutical companies, see annexpay attention to the announcement of the unit, is Heilongjiang Health Insurance Bureau, clearly indicated that it has taken over the drug recruitmentAccording to the Opinions on The Conformity Evaluation of Quality and Efficacy of Generic Drugs issued by the General Office of the State Council on March 5, 2016, it is clearly requested that more than 3 production enterprises with the same varieties of drugs that have passed the consistent evaluation shall no longer select varieties that have not passed the consistent evaluation in the areas of centralized procurement of medicines, in addition to Heilongjiang, Jiangxi, Guangxi, Jiangsu, Hubei and other provinces have suspended the procurement qualifications of the corresponding pharmaceutical companies because they have not passed the consistency evaluationin addition to the above provinces, according to Cypress Blue statistics, so far, Zhejiang, Hunan, Fujian, Tianjin, Hebei, Jilin, Liaoning, Shaanxi, Gansu and other provinces and cities, has issued a clear review of the non-consistent evaluation of drugs suspended procurementsuspended the hanging of the net this situation, according to Cypress Blue statistics, price reduction is not in place, enterprises actively apply, did not pass the consistency evaluation,certificate was withdrawn and revoked, will lead to the drug was canceled hanging net